DEA Rescheduling Paves Way for Cannabis Processors in Pharma and Biotech

On: May 30, 2024

Image

Cannabis News
May 30, 2024

DEA Rescheduling of Marijuana to Schedule III Sparks Major Opportunities for Cannabis Processors. The impending DEA rescheduling of marijuana to a Schedule III controlled substance presents a momentous opportunity for state-licensed cannabis processing businesses to diversify revenue streams

Cannabis Technology News

Medical Cannabis News

Marijuana Business News

PR Newswire

Read More: DEA Rescheduling Paves Way for Cannabis Processors in Pharma and Biotech

Previous Post: Florida Lawyer Who Funded Medical Marijuana Campaign Backs This Year’s Recreational Legalization Ballot Measure

Next Post: Illinois passes on banning synthetic Weed

Comments are closed, but trackbacks and pingbacks are open.